Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Glintborg, Bente ; Loft, Anne Gitte ; Omerovic, Emina ; Hendricks, Oliver ; Linauskas, Asta ; Espesen, Jakob ; Danebod, Kamilla ; Jensen, Dorte Vendelbo ; Nordin, Henrik ; Dalgaard, Emil Barner ; Chrysidis, Stavros ; Kristensen, Salome ; Raun, Johnny Lillelund ; Lindegaard, Hanne ; Manilo, Natalia ; Jakobsen, Susanne Højmark ; Hansen, Inger Marie Jensen ; Dalsgaard Pedersen, Dorte ; Sørensen, Inge Juul ; Andersen, Lis Smedegaard ; Grydehøj, Jolanta ; Mehnert, Frank ; Krogh, Niels Steen ; Hetland, Merete Lund. / To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry. In: Annals of the Rheumatic Diseases. 2019 ; Vol. 78, No. 2. pp. 192-200.

Bibtex

@article{357f843e6f5e402690a740e4ba42edbe,
title = "To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry",
author = "Bente Glintborg and Loft, {Anne Gitte} and Emina Omerovic and Oliver Hendricks and Asta Linauskas and Jakob Espesen and Kamilla Danebod and Jensen, {Dorte Vendelbo} and Henrik Nordin and Dalgaard, {Emil Barner} and Stavros Chrysidis and Salome Kristensen and Raun, {Johnny Lillelund} and Hanne Lindegaard and Natalia Manilo and Jakobsen, {Susanne H{\o}jmark} and Hansen, {Inger Marie Jensen} and {Dalsgaard Pedersen}, Dorte and S{\o}rensen, {Inge Juul} and Andersen, {Lis Smedegaard} and Jolanta Grydeh{\o}j and Frank Mehnert and Krogh, {Niels Steen} and Hetland, {Merete Lund}",
note = "COPECARE",
year = "2019",
doi = "10.1136/annrheumdis-2018-213474",
language = "English",
volume = "78",
pages = "192--200",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "B M J Group",
number = "2",

}

RIS

TY - JOUR

T1 - To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry

AU - Glintborg, Bente

AU - Loft, Anne Gitte

AU - Omerovic, Emina

AU - Hendricks, Oliver

AU - Linauskas, Asta

AU - Espesen, Jakob

AU - Danebod, Kamilla

AU - Jensen, Dorte Vendelbo

AU - Nordin, Henrik

AU - Dalgaard, Emil Barner

AU - Chrysidis, Stavros

AU - Kristensen, Salome

AU - Raun, Johnny Lillelund

AU - Lindegaard, Hanne

AU - Manilo, Natalia

AU - Jakobsen, Susanne Højmark

AU - Hansen, Inger Marie Jensen

AU - Dalsgaard Pedersen, Dorte

AU - Sørensen, Inge Juul

AU - Andersen, Lis Smedegaard

AU - Grydehøj, Jolanta

AU - Mehnert, Frank

AU - Krogh, Niels Steen

AU - Hetland, Merete Lund

N1 - COPECARE

PY - 2019

Y1 - 2019

U2 - 10.1136/annrheumdis-2018-213474

DO - 10.1136/annrheumdis-2018-213474

M3 - Journal article

VL - 78

SP - 192

EP - 200

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 2

ER -

ID: 56069941